A serious warning on Pfizer Inc’s (PFE.N) quit smoking drug should be removed, 10 of 19 independent panelists to the U.S. Food and Drug Administration recommended on Wednesday, after reviewing additional trial data on the controversial treatment.
Pfizer’s Chantix was approved about a decade ago, but thousands of reports of mental health problems in users led to the FDA imposing the “black box” warning – the most severe available – in 2009.
Source: Reuters
Filed Under: Drug Discovery